On September 23, 2026, BMO Capital initiated coverage of Ardent Health (NYSE: ARDT) with a Market Perform recommendation. On the same day, the stock closed at $10.64, down from $10.95 on September 22, 2026. Over the past month, the stock’s price decreased by 3.18% from its close of $10.99 on August 21, 2026.
As of September 15, 2026, the consensus target mean for Ardent Health’s stock is $13.11, with a median of $13.26, indicating an expected increase of 23.19%. In its August 4, 2026 earnings report, Ardent Health reported an EPS of 0.12, missing the estimated 0.1848 by 35.06%, despite revenue hitting $1.62 billion, slightly above estimated revenue of $1.62 billion.
The overall analyst sentiment for Ardent Health remains stable, with 18 recommendations: 5 strong buy, 7 buy, 5 hold, and 1 sell, reflecting 66.7% positivity. Additionally, Leerink Partners maintained its Outperform rating on September 18, 2026.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
